Congratulations, Dr. James P. Allison, on the 2018 Nobel Prize in Physiology or Medicine from all of us at the Cancer Research Institute. James P. Allison, Ph.D., is the Director of the Cancer Research Institute's Scientific Advisory Council.
Dr. Allison is the chair of Immunology, the executive director of the Immunotherapy Platform, and deputy director for Applied Research of Genitourinary Cancers at the University of Texas MD Anderson Cancer Center. Dr. Allison, who also serves on the National Cancer Moonshot Blue Ribbon Panel, helped identify the T cell antigen receptor, and discovered that blocking the CTLA-4 receptor on T cells enhances the immune system’s ability to eliminate tumors. This led to the development of the first approved checkpoint immunotherapy, the anti-CTLA-4 ipilimumab. In addition to being named a recipient of the 2018 Nobel Prize in Medicine or Physiology, Dr. Allison has received many awards. [ Ссылка ]
Estbalished in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization that is dedicated to harnessing our immune system's power to control and potentially cure all types of cancer. To accomplish this. we fund the most innovative clinical and laboratory research around the world, support the next generation of the field's leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. Our Mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. [ Ссылка ]
(c) Cancer Research Institute 2018.
Musicbed SyncID:
MB01QRF8Q0MRQAW
